Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response
Chiara Fabbri, Ladislav Hosák, Rainald Mößner, et al.
The World Journal of Biological Psychiatry (2016) Vol. 18, Iss. 1, pp. 5-28
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Prognosis and improved outcomes in major depression: a review
Christoph Kraus, Bashkim Kadriu, Rupert Lanzenberger, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 389
Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications
Zezhi Li, Meihua Ruan, Jun Chen, et al.
Neuroscience Bulletin (2021) Vol. 37, Iss. 6, pp. 863-880
Open Access | Times Cited: 254
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 202-277
Open Access | Times Cited: 164
Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects
A. Becker, Friederike Holze, Tanja Grandinetti, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 111, Iss. 4, pp. 886-895
Open Access | Times Cited: 133
A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder
Kelly Perlman, David Benrimoh, Sonia Israel, et al.
Journal of Affective Disorders (2018) Vol. 243, pp. 503-515
Closed Access | Times Cited: 155
The potential of predictive analytics to provide clinical decision support in depression treatment planning
Ronald C. Kessler
Current Opinion in Psychiatry (2017) Vol. 31, Iss. 1, pp. 32-39
Closed Access | Times Cited: 91
Depression: Biological markers and treatment
Gordana Nedić Erjavec, Marina Šagud, Matea Nikolac Perković, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 105, pp. 110139-110139
Closed Access | Times Cited: 88
Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Major Depressive Disorder (MDD): A Systematic Review
Mario Ignacio Zelada, Verónica Garrido, Andrés Liberona, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14810-14810
Open Access | Times Cited: 30
Chinese medicine formula Kai-Xin-San ameliorates depression-like behaviours in chronic unpredictable mild stressed mice by regulating gut microbiota-inflammation-stress system
Cheng Cao, Mengqiu Liu, Suchen Qu, et al.
Journal of Ethnopharmacology (2020) Vol. 261, pp. 113055-113055
Closed Access | Times Cited: 63
Prognosis and Improved Outcomes in Major Depression: A Review
Christoph Kraus, Bashkim Kadriu, Rupert Lanzenberger, et al.
FOCUS The Journal of Lifelong Learning in Psychiatry (2020) Vol. 18, Iss. 2, pp. 220-235
Open Access | Times Cited: 59
Interleukin-6 Gene Expression Changes after a 4-Week Intake of a Multispecies Probiotic in Major Depressive Disorder—Preliminary Results of the PROVIT Study
Alexandra Reiter, Susanne Bengesser, Anne-Christin Hauschild, et al.
Nutrients (2020) Vol. 12, Iss. 9, pp. 2575-2575
Open Access | Times Cited: 52
DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder
Alladi Charanraj Goud, Bruno Étain, Frank Bellivier, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3026-3026
Open Access | Times Cited: 57
Diurnal Hypothalamic-Pituitary-Adrenal Axis Measures and Inflammatory Marker Correlates in Major Depressive Disorder
Kelly Doolin, Chloë Farrell, Leonardo Tozzi, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 10, pp. 2226-2226
Open Access | Times Cited: 55
FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression
Marcus Ising, Giuseppina Maccarrone, Tanja Brückl, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 485-485
Open Access | Times Cited: 54
Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm
Paul R. Albert, Brice Le François, Faranak Vahid-Ansari
Journal of Psychiatry and Neuroscience (2019) Vol. 44, Iss. 3, pp. 164-176
Open Access | Times Cited: 52
Schizophrenia: A Narrative Review of Etiopathogenetic, Diagnostic and Treatment Aspects
Laura Orsolini, Simone Pompili, Umberto Volpe
Journal of Clinical Medicine (2022) Vol. 11, Iss. 17, pp. 5040-5040
Open Access | Times Cited: 25
BDNF Plasma Levels and BDNF Exon IV Promoter Methylation as Predictors for Antidepressant Treatment Response
Klaus Lieb, Nadine Dreimüller, Stefanie Wagner, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 46
Effects of selective serotonin reuptake inhibitors on DNA damage in patients with depression
Mahnaz Ahmadimanesh, Mohammad Reza Abbaszadegan, Dorsa Morshedi Rad, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 11, pp. 1364-1376
Closed Access | Times Cited: 42
A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments
María J. Arranz, Alex Gonzalez-Rodriguez, Josefina Pérez‐Blanco, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 40
Cannabinoid CB2 Receptor Gene and Environmental Interaction in the Development of Psychiatric Disorders
Hiroki Ishiguro, Yasue Horiuchi, Koichi Tabata, et al.
Molecules (2018) Vol. 23, Iss. 8, pp. 1836-1836
Open Access | Times Cited: 39
Precision pharmacotherapy: psychiatry’s future direction in preventing, diagnosing, and treating mental disorders
Andreas Menke
Pharmacogenomics and Personalized Medicine (2018) Vol. Volume 11, pp. 211-222
Open Access | Times Cited: 39
Effects of early life stress on brain cytokines: A systematic review and meta-analysis of rodent studies
Francisco Sindermann Lumertz, Érika Kestering-Ferreira, Rodrigo Orso, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 139, pp. 104746-104746
Open Access | Times Cited: 22
The Combination of Long-term Ketamine and Extinction Training Contributes to Fear Erasure by Bdnf Methylation
Ling-Sha Ju, Jiaojiao Yang, Lei Lei, et al.
Frontiers in Cellular Neuroscience (2017) Vol. 11
Open Access | Times Cited: 34
Investigating the epigenetic profile of the inflammatory gene IL-6 in late-life depression
Joanne Ryan, Lauren Pilkington, K Neuhaus, et al.
BMC Psychiatry (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 33
Acute stress response to a cognitive task in patients with major depressive disorder: potential metabolic and proinflammatory biomarkers
Т. А. Дружкова, Ksenia Pochigaeva, А. А. Yakovlev, et al.
Metabolic Brain Disease (2018) Vol. 34, Iss. 2, pp. 621-629
Closed Access | Times Cited: 30
Page 1 - Next Page

Scroll to top